At the start of a new decade, with exponential pace and scale-up of technological innovation, the questioning of fundamental conventions around value, risk, rewards, and the role of public and private sectors come to the forefront. Is the way we currently establish, incentivize, and share value sustainable for health systems, patients, and technology developers? If not, why; and how should we share risks and rewards more appropriately? What are the new methodologies needed to establish and assess value, determine how it’s shared, and ensure that we can sustain innovation? Are we providing the right incentives to assure we address healthcare problems that bring the most value to society? Medical innovation has shown immense technological progress in the areas of personalized medicine and rare disease. But are these the best areas for continuing investment? And what can we do to help extend progress to broader public health concerns such as antimicrobial resistance? These and other challenging questions will be addressed by the global HEOR community at ISPOR Europe 2020.
Join us on 14-18 November 2020 in Milan, Italy, to lead the transformation in healthcare decision making in the next decade!